Rules and Regulations. Final order; correction
188 words·~1 min read·
/register/2018/03/14/2018-05115·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 1301-00-D DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 864 [Docket No. FDA-2018-N-0399] Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Final order; correction. SUMMARY: The Food and Drug Administration is correcting a final order entitled “Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems” that appeared in the **Federal Register** of February 27, 2018.
The document was published with the incorrect docket number. This document corrects that error. DATES: Effective March 14, 2018. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg, 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115. SUPPLEMENTARY INFORMATION: In the **Federal Register** of February 27, 2018 (83 FR 8355), in FR Doc. 2018-03924, on page 8355, the following correction is made: 1.
On page 8355, in the third column, in the header of the document, the docket number is corrected to read “FDA-2018-N-0399”. Dated: March 8, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018-05115 Filed 3-13-18; 8:45 am]
Connections1 off-index
1 reference not yet in our index
- 21 CFR 864
Citation graph
cites case law
Rules and Regulations
Final order; correction
Cite21 CFR 864
Cites 1Cited by 0 across 0 sources